Labeler
BluePoint Laboratories NDC Codes
BluePoint Laboratories lists 349 finished drug products in the FDA NDC Directory under NDC labeler code 68001.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Enoxaparin Sodium, Nadolol, Dasatinib, doxorubicin hydrochloride, Metoprolol Succinate, Aprepitant, Zenatane, Decitabine, Labetalol Hydrochloride, Cyclophosphamide, Fluoxetine, Etoposide, Haloperidol decanoate, leucovorin calcium, Mitomycin
- Active ingredients
- Enoxaparin sodium, Nicotine, Nadolol, Dasatinib, Doxorubicin hydrochloride, Metoprolol succinate, Isotretinoin, Decitabine, Labetalol hydrochloride, Cyclophosphamide, Aprepitant, Fluoxetine hydrochloride
- NDC labeler codes
- 68001
- Strengths (from the 100 most recently listed products)
- Doxorubicin hydrochloride 2 mg/mL; Enoxaparin sodium 100 mg/mL; Etoposide 20 mg/mL; Decitabine 50 mg/10mL; Nicotine 7 mg/24h; Nicotine 14 mg/24h; Nicotine 21 mg/24h; Nadolol 20 mg/1; Nadolol 40 mg/1; Nadolol 80 mg/1; Enoxaparin sodium 150 mg/mL; Fluorouracil 50 mg/mL; Cisplatin 1 mg/mL; Palonosetron hydrochloride .25 mg/5mL; Labetalol hydrochloride 300 mg/1; Paclitaxel 6 mg/mL; Teriparatide 250 ug/mL; Cyclophosphamide 500 mg/25mL; Cyclophosphamide 1 g/50mL; Cyclophosphamide 2 g/100mL
- Dosage forms
- Injection, Tablet, Tablet, Film coated, Injection, Powder, Lyophilized, For solution, Patch, Extended release, Capsule, Injection, Solution, Tablet, Extended release, Capsule, Gelatin coated, Injection, Solution, Concentrate, Injection, Suspension, Liposomal, Injection, Powder, For solution, Injectable, Liposomal, Solution, Tablet, Film coated, Extended release, Kit, Patch, Injection, Powder, Lyophilized, For suspension, Gel, Spray, Capsule, Extended release
- Routes
- Oral, Intravenous, Subcutaneous, Intramuscular, Transdermal, Topical, Ophthalmic, Nasal
- Drug classes (FDA established)
- beta-Adrenergic Blocker, Nucleoside Metabolic Inhibitor, Kinase Inhibitor, Low Molecular Weight Heparin, Cholinergic Nicotinic Agonist, Anthracycline Topoisomerase Inhibitor, Serotonin Reuptake Inhibitor, Substance P/Neurokinin-1 Receptor Antagonist, Retinoid, Microtubule Inhibitor, Topoisomerase Inhibitor, Typical Antipsychotic, Folate Analog, Alkylating Drug, Anti-epileptic Agent, Mood Stabilizer, Nonsteroidal Anti-inflammatory Drug, Aminoketone, Bisphosphonate, Platinum-based Drug, Serotonin-3 Receptor Antagonist, Parathyroid Hormone Analog, Histamine-1 Receptor Antagonist, Histamine-1 Receptor Inhibitor, Mast Cell Stabilizer, Cytochrome P450 17A1 Inhibitor, Amide Local Anesthetic, Antiarrhythmic, Corticosteroid, Opioid Antagonist, Vitamin B12, Estrogen Receptor Antagonist, Osmotic Laxative, Potassium Salt
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 131 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Olopatadine Hydrochloride | Olopatadine hydrochloride 2 mg/mL | SolutionOphthalmic | 68001-530 | 68001-0530-69 | — |
| Zinc Oxideskin protectant | Zinc oxide 20 g/100g | OintmentTopical | 68001-533 | 68001-0533-50 | — |
| Zinc Oxideskin protectant | Zinc oxide 20 g/100g | OintmentTopical | 68001-532 | 68001-0532-4568001-0532-46 | — |
| Meclizine HClmeclizine hydrochloride chewable | Meclizine hydrochloride 25 mg/1 | Tablet, ChewableOral | 68001-529 | 68001-0529-0068001-0529-08 | — |
| Meclizine HClmeclizine hydrochloride | Meclizine hydrochloride 12.5 mg/1 | TabletOral | 68001-528 | 68001-0528-00 | — |
| Bacitracin Zincfirst aid antibiotic | Bacitracin zinc 500 [USP'U]/g | OintmentTopical | 68001-531 | 68001-0531-4568001-0531-46 | — |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | 68001-525 | 68001-0525-2768001-0525-32 | — |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | 68001-524 | 68001-0524-3068001-0524-31 | — |
| Azacitidine | Azacitidine 100 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous, Subcutaneous | 68001-527 | 68001-0527-54 | — |
| Fosaprepitantfosaprepitant dimeglumine | Fosaprepitant dimeglumine 150 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-523 | 68001-0523-36 | — |
| Bupropion Hydrochloride | Bupropion hydrochloride 150 mg/1 | Tablet, Extended releaseOral | 68001-519 | 68001-0519-0368001-0519-0468001-0519-05 | — |
| Bupropion Hydrochloride | Bupropion hydrochloride 300 mg/1 | Tablet, Extended releaseOral | 68001-520 | 68001-0520-0368001-0520-0468001-0520-05 | — |
| Fulvestrant | Fulvestrant 250 mg/5mL | InjectionIntramuscular | 68001-522 | 68001-0522-85 | — |
| Paclitaxel | Paclitaxel 6 mg/mL | Injection, SolutionIntravenous | 68001-516 | 68001-0516-27 | — |
| Potassium Chloride | Potassium chloride 750 mg/1 | Tablet, Film coated, Extended releaseOral | 68001-518 | 68001-0518-0068001-0518-08 | — |
| Piperacillin and Tazobactam | Piperacillin sodium 2 g/10mL; Tazobactam sodium .25 g/10mL | Injection, Powder, For solutionIntravenous | 68001-506 | 68001-0506-30 | — |
| Piperacillin and Tazobactam | Piperacillin sodium 3 g/15mL; Tazobactam sodium .375 g/15mL | Injection, Powder, For solutionIntravenous | 68001-507 | 68001-0507-82 | — |
| Piperacillin and Tazobactam | Piperacillin sodium 4 g/20mL; Tazobactam sodium .5 g/20mL | Injection, Powder, For solutionIntravenous | 68001-508 | 68001-0508-31 | — |
| Polyethylene Glycol | Polyethylene glycol 3350 17 g/17g | Powder, For suspensionOral | 68001-505 | 68001-0505-5568001-0505-69 | — |
| Triple Antibioticfirst aid antibiotic | Neomycin sulfate 3.5 mg/g + 2 more ingredients | OintmentTopical | 68001-483 | 68001-0483-4568001-0483-46 | — |
| Metaxalone | Metaxalone 800 mg/1 | TabletOral | 68001-485 | 68001-0485-00 | — |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injectable, LiposomalIntravenous | 68001-492 | 68001-0492-36 | — |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injectable, LiposomalIntravenous | 68001-493 | 68001-0493-26 | — |
| Metoprolol Succinatemetoprolol succinate er tablets | Metoprolol succinate 100 mg/1 | Tablet, Film coated, Extended releaseOral | 68001-502 | 68001-0502-0068001-0502-03 | — |
| Metoprolol Succinatemetoprolol succinate er tablets | Metoprolol succinate 25 mg/1 | Tablet, Film coated, Extended releaseOral | 68001-500 | 68001-0500-0068001-0500-03 | — |
| Metoprolol Succinatemetoprolol succinate er tablets | Metoprolol succinate 50 mg/1 | Tablet, Film coated, Extended releaseOral | 68001-501 | 68001-0501-0068001-0501-03 | — |
| Metoprolol Succinatemetoprolol succinate er tablets | Metoprolol succinate 200 mg/1 | Tablet, Film coated, Extended releaseOral | 68001-503 | 68001-0503-00 | — |
| Lisinopril | Lisinopril 40 mg/1 | TabletOral | 68001-486 | 68001-0486-0068001-0486-08 | — |
| Venlafaxine Hydrochloridevenlafaxine | Venlafaxine hydrochloride 150 mg/1 | Tablet, Extended releaseOral | 68001-498 | 68001-0498-04 | — |
| Acetaminophen | Acetaminophen 650 mg/1 | TabletOral | 68001-495 | 68001-0495-00 | — |
| Venlafaxine Hydrochloridevenlafaxine | Venlafaxine hydrochloride 37.5 mg/1 | Tablet, Extended releaseOral | 68001-496 | 68001-0496-04 | — |
| Venlafaxine Hydrochloridevenlafaxine | Venlafaxine hydrochloride 75 mg/1 | Tablet, Extended releaseOral | 68001-497 | 68001-0497-04 | — |
| Venlafaxine Hydrochloridevenlafaxine | Venlafaxine hydrochloride 225 mg/1 | Tablet, Extended releaseOral | 68001-499 | 68001-0499-04 | — |
| Famotidine | Famotidine 10 mg/1 | TabletOral | 68001-494 | 68001-0494-0468001-0494-06 | — |
| imatinib mesylate | Imatinib mesylate 400 mg/1 | Tablet, Film coatedOral | 68001-491 | 68001-0491-04 | — |
| imatinib mesylate | Imatinib mesylate 100 mg/1 | Tablet, Film coatedOral | 68001-490 | 68001-0490-05 | — |
| Fulvestrant | Fulvestrant 250 mg/5mL | Injection, SolutionIntramuscular | 68001-484 | 68001-0484-85 | — |
| Capecitabine | Capecitabine 150 mg/1 | Tablet, Film coatedOral | 68001-487 | 68001-0487-06 | — |
| Capecitabine | Capecitabine 500 mg/1 | Tablet, Film coatedOral | 68001-488 | 68001-0488-07 | — |
| Potassium Chloride Extended-release | Potassium chloride 1500 mg/1 | TabletOral | 68001-567 | 68001-0567-0068001-0567-03 | — |
| Potassium Chloride Extended-release | Potassium chloride 750 mg/1 | TabletOral | 68001-566 | 68001-0566-0068001-0566-03 | — |
| Divalproex Sodium | Divalproex sodium 250 mg/1 | Tablet, Delayed releaseOral | 68001-473 | 68001-0473-0068001-0473-03 | — |
| Divalproex Sodium | Divalproex sodium 125 mg/1 | Tablet, Delayed releaseOral | 68001-472 | 68001-0472-0068001-0472-03 | — |
| Divalproex Sodium | Divalproex sodium 500 mg/1 | Tablet, Delayed releaseOral | 68001-474 | 68001-0474-0068001-0474-03 | — |
| Irinotecan hydrochloide | Irinotecan hydrochloride 20 mg/mL | InjectionIntravenous | 68001-480 | 68001-0480-2268001-0480-35 | — |
| Oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | 68001-468 | 68001-0468-3668001-0468-37 | — |
| Antifungal Creamantifungal | Miconazole nitrate 2 g/100g | CreamTopical | 68001-481 | 68001-0481-4568001-0481-4768001-0481-48 | — |
| Hydrocortisoneantipruritic (anti-itch) | Hydrocortisone 1 g/100g | CreamTopical | 68001-476 | 68001-0476-4668001-0476-50 | — |
| Antifungal Creamantifungal | Clotrimazole 1 g/100g | CreamTopical | 68001-475 | 68001-0475-4568001-0475-47 | — |
| Bacitracin | Bacitracin 500 [iU]/g | OintmentTopical | 68001-477 | 68001-0477-4668001-0477-4768001-0477-48 | — |
BluePoint Laboratories: common questions
- What is BluePoint Laboratories's NDC labeler code?
- 68001. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for BluePoint Laboratories?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.